Review Article

Efficacy and Safety of Traditional Chinese Medicine in the Treatment of Immune Infertility Based on the Theory of “Kidney Deficiency and Blood Stasis”: A Systematic Review and Meta-Analysis

Table 1

Basic characteristics of the included study.

Author(s)Sample size Expt./Ctrl.Average age (y) Expt./Ctrl.GenderDiagnosticsIntervention measuresDuration treatmentOutcome measures
Expt.Ctrl.

Wu [6]31/3132.6/31.4FemaleA + B + CBushen Huoxue decoction + WMPrednisone + clomiphene + vitamins C, E3m ∗ 2
Lu and Gong [7]28/2826.34/27.12FemaleA + CXiaokang II decoctionAspirin2m ∗ 2⑥⑦
Chen and Xu [8]30/3027.03/26.67FemaleA + B + CBushenyikang decoctionPrednisone1m ∗ 3①②⑦
Ma and Zhang [9]46/4431.2/31.4FemaleA + B + CYikang Zhuyun decoctionPrednisolone14d ∗ 3①⑦
Liu et al. [10]176/8233.5/33.5FemaleA + B + CBushen Huoxue decoction + WMVitamin C + aspirin + prednisone21d ∗ 2①⑦
Liu [11]35/3529.33/29.25FemaleA + B + CBushen Huoxue decoction + WMPrednisone3m ∗ 3①②⑦⑧
Cai et al. [12]40/4028.76/30.72FemaleA + B + CHuoxue Xiaokang decoctionPrednisone + acetate aspirin45d ∗ 2①③⑦
Zhong et al. [13]70/6527.8/27.8FemaleA + B + CBushen Huoxue decoctionPrednisone1m ∗ 3①②③④⑤⑦⑧
Qi et al. [14]78/6029.5/29.5FemaleA + B + CYulin Qingkang decoctionDexamethasone1m × 3①②③⑥⑦
Wu [15]69/5028.35/28.35FemaleA + B + CAssisting-pregnancy decoctionDexamethasone2m × 1①⑦
Zhao [16]56/3528.35/28.35FemaleA + B + CAnti-immunity I tabletPrednisone2m ∗ 3①②⑦⑧
Fu [17]23/2128.1/28.1FemaleA + B + CBushen Huoxue Xiaokang decoction + WMEnteric-coated aspirin + prednisone + vitamin C14d ∗ 1①⑦
Liang and Yuan [18]48/47FemaleA + B + CBushen Huoxue Xiaokang decoction + WMEnteric-coated aspirin + prednisone + vitamin C14d ∗ 2①⑦

Expt.: experimental group; Ctrl.: control group; A: diagnostic criteria for infertility: unable to conceive after one year or longer of unprotected sex; B: ruling out infertility due to other factors, such as tubal obstruction, ovulation disorders, and endometriosis; C: positive for at least one of the following serum antibody tests: AsAb, AEmAb, ACAb, AoAb, AZPAb, and AhCGAb. ① Total effective rate; ② serum AsAb negative conversion rate; ③ serum AEmAb negative conversion rate; ④ serum AoAb negative conversion rate; ⑤ serum AhCGAb negative conversion rate; ⑥ ACAb negative conversion rate; ⑦ pregnancy rate; and ⑧ adverse effects.